Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel

BACKGROUND: Inflammation is a key factor in the development of atherosclerotic disease and acute coronary syndromes (ACS). The P2Y(12) receptor antagonists ticagrelor (AZD6140) and clopidogrel may have anti‐inflammatory effects. The objective of this analysis from the Dose Confirmation Study Assessi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Husted, Steen, Storey, Robert F., Harrington, Robert A., Emanuelsson, Håkan, Cannon, Christopher P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2010
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653411/
https://ncbi.nlm.nih.gov/pubmed/20394040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20732
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares